Showing results (21-30 of 6,950) with videos related to
Sort By:
Pageof 695
Journal of Clinical Pharmacology|November 5, 2002
Marijuana withdrawal syndrome in the animal modelAron H Lichtman, Billy R MartinJournal of Clinical Pharmacology|November 5, 2002
Development and consequences of cannabis dependenceAlan J Budney, Brent A MooreJournal of Clinical Pharmacology|November 5, 2002
Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic reviewRaul Gonzalez, Catherine Carey, Igor GrantJournal of Clinical Pharmacology|November 5, 2002
Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patientsBarry M Bredt, Dana Higuera-Alhino, Starley B Shade, et al.Journal of Clinical Pharmacology|November 5, 2002
Marijuana smoking and head and neck cancerMia Hashibe, Daniel E Ford, Zuo-Feng ZhangJournal of Clinical Pharmacology|December 5, 2002
Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteersJosep M Jansat, Joan Costa, Pau Salvà, et al.Journal of Clinical Pharmacology|December 5, 2002
Microsomal enzyme induction and clinical aggravation of porphyria: the evaluation of human urinary 6beta-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activityEtsuko Uejima, Kyoko Takahashi, Tomoko Morisaki, et al.Journal of Clinical Pharmacology|September 3, 1999
Microbial biofilms: their development and significance for medical device-related infectionsM Habash, G ReidJournal of Clinical Pharmacology|September 3, 1999
FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labelingB Davit, K Reynolds, R Yuan, et al.Journal of Clinical Pharmacology|January 13, 2000
Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failureS I Sokol, A Cheng, W H Frishman, et al.Pageof 695